On Monday, Metagenomi Inc (NASDAQ: MGX) was 125.41% up from the session before settling in for the closing price of $1.85. A 52-week range for MGX has been $1.61 – $12.74.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 3569.20% over the last five years. When this article was written, the company’s average yearly earnings per share was at 87.64%. With a float of $18.78 million, this company’s outstanding shares have now reached $37.43 million.
The firm has a total of 236 workers. Let’s measure their productivity. In terms of profitability, gross margin is 93.13%, operating margin of -160.63%, and the pretax margin is -137.13%.
Metagenomi Inc (MGX) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Metagenomi Inc stocks. The insider ownership of Metagenomi Inc is 49.81%, while institutional ownership is 25.17%. The most recent insider transaction that took place on Dec 05 ’24, was worth 2,900. In this transaction Chief Financial Officer of this company sold 1,559 shares at a rate of $1.86, taking the stock ownership to the 61,492 shares. Before that another transaction happened on Sep 05 ’24, when Company’s Chief Financial Officer sold 6,265 for $2.88, making the entire transaction worth $18,043. This insider now owns 63,051 shares in total.
Metagenomi Inc (MGX) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.69 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 87.64% per share during the next fiscal year.
Metagenomi Inc (NASDAQ: MGX) Trading Performance Indicators
You can see what Metagenomi Inc (MGX) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 6.18. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.83.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.50, a number that is poised to hit -0.75 in the next quarter and is forecasted to reach -2.66 in one year’s time.
Technical Analysis of Metagenomi Inc (MGX)
Analysing the last 5-days average volume posted by the [Metagenomi Inc, MGX], we can find that recorded value of 13.13 million was better than the volume posted last year of 0.5 million. As of the previous 9 days, the stock’s Stochastic %D was 39.78%. Additionally, its Average True Range was 0.34.
During the past 100 days, Metagenomi Inc’s (MGX) raw stochastic average was set at 73.35%, which indicates a significant decrease from 89.51% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 335.04% in the past 14 days, which was higher than the 149.21% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.0200, while its 200-day Moving Average is $5.1400. Now, the first resistance to watch is $4.9400. This is followed by the second major resistance level at $5.7200. The third major resistance level sits at $6.9600. If the price goes on to break the first support level at $2.9200, it is likely to go to the next support level at $1.6800. Now, if the price goes above the second support level, the third support stands at $0.9000.
Metagenomi Inc (NASDAQ: MGX) Key Stats
There are 37,424K outstanding shares of the company, which has a market capitalization of 156.05 million. As of now, sales total 44,760 K while income totals -68,260 K. Its latest quarter income was 11,510 K while its last quarter net income were -18,770 K.
